Romosozumab

Dec 12, 2019

European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture

Jun 28, 2019

Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU

Jan 16, 2019

Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY(TM) (romosozumab)

Jan 08, 2019

EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture

Jul 13, 2018

Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA

Jan 08, 2018

European Medicines Agency Accepts Filing For EVENITY(TM) (Romosozumab)

Sep 11, 2017

EVENITY(TM) (romosozumab) ARCH Study Results Published In The New England Journal Of Medicine